Effects of isradipine on intravenous cocaine-induced cardiovascular response: A pilot study

Human Psychopharmacology

Volumn 14, Issue 1, 1999, Pages 37-43

  Johnson, Bankole ^a,b   Wells, Lynda ^b,c   Kenny, Paul ^c   Abramson, David ^c   Chen, Richard ^a   Dhother, Sukhjinder ^c   Overton, Dennis ^c   Bordnick, Patrick ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Calcium channel antagonist; Cardiac rhythm; Cardiovascular; Cocaine; EKG; Human; Isradipine; Oxygen saturation

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; COCAINE; ISRADIPINE;

ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR EFFECT; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; ELECTROCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEART PROTECTION; HEART RATE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MONITORING; ORAL DRUG ADMINISTRATION; OXYGEN SATURATION; PRESSOR RESPONSE; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE;

EID: 0032904553     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(199901)14:1<37::AID-HUP62>3.0.CO;2-T     Document Type: Article

References (27)

1. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. APA, Washington.
2. Apostolakos, M. J. and Varon, M. E. (1996). Antiarrhythmic and anti-ischemic properties of calcium-channel antagonists. New Horizons, 4(1), 45-57.
3. Billman, G. E. (1995). Cocaine: a review of its toxic actions on cardiac function. Critical Reviews in Toxicology, 25(2), 113-132.
4. Brogden, R. N. and Sorkin, E. M. (1995). Isradipine. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of mild to moderate hypertension. Drugs, 49(4), 618-649.
5. Carrara, V., Porchet, H. and Dayer, P. (1990). The effect of rate of administration of isradipine on the hemodynamic response. Schweizerische Medizinische Wochenschrift, 120(49), 1894-1896.
6. Carrara, V., Porchet, H. and Dayer, P. (1994). Influence of input rates on (±)-isradipine haemodynamics and concentration effect. European Journal of Pharmacology, 46, 29-33.
7. Chakko, S. and Myerburg, R. J. (1995). Cardiac complications of cocaine abuse. Clinical Cardiology, 18, 67-72.
8. Daras, M., Tuchman, A. J., Koppel, B. S. et al. (1994). Neurovascular complications of cocaine. Acta Neurolgica Scandinavica, 90, 124-129.
9. Foltin, R. W. and Fischman, M. W. (1991). Smoked and intravenous cocaine in humans: acute tolerance, cardiovascular, and subjective effects. Journal of Pharmacology and Experimental Therapeutics, 257(1), 247-261.
10. Foltin, R. W., Christiansen, I., Levin, F. R. et al. (1995). Effects of single and multiple intravenous cocaine injections in humans maintained on methadone. Journal of Pharmacology and Experimental Therapeutics, 275(1), 38-47.
11. Gaggi, R., Dall'Olio, R., Roncada, P. and Gianni, A. M. (1995). Peculiar effects of isradipine and darodipine on the rat dopaminergic system. General Pharmacology, 26(2), 303-308.
12. Havranek, E. P., Nademanee, K., Grayburn, P. A. and Eichhorm, E. J. (1996). Endothelium-dependent vaso-relaxation is impaired in cocaine arteriopathy. Journal of the American College of Cardiology, 28, 1168-1174.
13. Hemby, S. E., Johnson, B. A. and Dworkin, S. I. (1997). Neurobiological basis of drug addiction. In: Drug Addiction and its Treatment - Nexus of Neuroscience and Behavior. Raven Press, New York.
14. Irwin, K., Edlin, B. R., Faruque, S. and McCoy, H. V. (1996). Crack cocaine users who turn to drug injection: characteristics, factors associated with injection, and implications for HIV transmission. Drug and Alcohol Dependence, 42, 85-92.
15. Leslie, J. B. (1993). Haemodynamics and tissue specificity with isradipine. Acta Anaesthesiol Scandinavica, 37(99), 33-37.
16. McLellan, A. T., Luborsky, L., Cacciola, J., Griffiths, J., Evans, F., Barr, H. and O'Brien, C. (1986). New data from the addiction severity index: reliability and validity scores from three centres. Journal of Nervous and Mental Disease, 173, 412-423.
17. Mosby (1997). Mosby's Complete Drug Reference, 7th edn. Mosby-Year Book Inc., St Louis, MI.
18. Muntaner, C., Kumor, K. M., Nagoshi, C. et al. (1991). Effects of nifedipine pretreatment on subjective and cardiovascular responses to intravenous cocaine in humans. Psychopharmacology, 105(1), 37-41.
19. Nahas, G., Trouve, R., Demus, J. F. and von Sitbon, M. (1985). A calcium channel blocker as antidote to the cardiac effects of cocaine intoxication. New England Journal of Medicine, 313(8), 519-520.
20. Perez-Vizcaino, F., Tamargo, J., Hof, R. P. et al. (1993). Vascular selectivity of seven prototype calcium antagonists: a study at the single cell level. Journal of Cardiovascular Pharmacology, 22(5), 768-775.
21. Pottieger, A. E., Tressell, P. A., Surratt, H. L. and Iniciardi, J. A. (1995). Drug use patterns of adult crack users in street versus residential treatment samples. Journal of Psychoactive Drugs, 27, 27-38.
22. ™ Users Guide 6-11 (1992). SAS Institute Inc., SAS Circle, Box 8000, Cary, NC 27512-8000.
23. Siegel, A. J., Scholar, M. B., Kaufman, M. J. et al. (1997). Erythrocytemia ('blood-doping') due to splenic contraction after intravenous cocaine. Abstract presented at College on the Problems of Drug Dependence, Nashville, TN, p. 140.
24. Shannon, R. P., Manders, W. T. and Shen, Y. T. (1995). Role of blood doping in the coronary vasoconstrictor response to cocaine. Circulation, 92, 96-105.
25. Slonim, A., Paran, E. and Christal, N. (1991). Effects of isradipine on factors affecting blood viscosity. American Journal of Hypertension, 4(2 pt 2), 172S-174S.
26. Trouve, R. and Nahas, G. (1986). Nitrendipine: an antidote to cardiac and lethal toxicity of cocaine. Proceedings of the Society for Experimental Biology and Medicine, 183(3), 392-397.
27. Williams, R. G., Kavanagh, K. M. and Teo, K. K. (1996). Pathophysiology and treatment of cocaine toxicity: implication for the heart and cardiovascular system. Canadian Journal of Cardiology, 12(12), 1295-1301.